ReviewTherapeutic advances in urology

Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.